These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 15841555)

  • 21. Reduction in cardiovascular events with atorvastatin in type 2 diabetes.
    Clearfield M
    Curr Atheroscler Rep; 2006 Jan; 8(1):9-10. PubMed ID: 16455007
    [No Abstract]   [Full Text] [Related]  

  • 22. [The periodic flashes of E. Brunwald: lowering cholesterol levels in subjects with myocardial infarction and normal cholesterol levels].
    Prati PL
    G Ital Cardiol; 1997 Jan; 27(1):76-8. PubMed ID: 9244714
    [No Abstract]   [Full Text] [Related]  

  • 23. Trends in the prevalence, awareness, treatment, and control of cardiovascular disease risk factors among noninstitutionalized patients with a history of myocardial infarction and stroke.
    Muntner P; DeSalvo KB; Wildman RP; Raggi P; He J; Whelton PK
    Am J Epidemiol; 2006 May; 163(10):913-20. PubMed ID: 16597707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Wider role seen for "remarkable" statins. Study suggests that benefits extend even to those with "normal" cholesterol levels.
    Heart Advis; 2002 Jan; 5(1):3. PubMed ID: 16145760
    [No Abstract]   [Full Text] [Related]  

  • 25. Prevention of macrovascular disease in patients with diabetes mellitus: opportunities for intervention.
    Mazzone T
    Am J Med; 2007 Sep; 120(9 Suppl 2):S26-32. PubMed ID: 17826043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The super pill that prevents myocardial infarction].
    Graff-Iversen S; Istad H
    Tidsskr Nor Laegeforen; 1992 Jun; 112(16):2119. PubMed ID: 1523640
    [No Abstract]   [Full Text] [Related]  

  • 27. I've recently been diagnosed with type 2 diabetes. What steps can I take to manage it properly and keep my blood sugar levels contained?
    Duke Med Health News; 2012 Mar; 18(3):8. PubMed ID: 22745982
    [No Abstract]   [Full Text] [Related]  

  • 28. Who does not need a statin: too late in end-stage renal disease or heart failure?
    Laufs U; Custodis F; Böhm M
    Postgrad Med J; 2009 Apr; 85(1002):187-9. PubMed ID: 19417167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. No age limit for cholesterol-lowering benefits. Older people gain as much as younger people from cholesterol-lowering statins.
    Harv Heart Lett; 2003 Mar; 13(7):4. PubMed ID: 12654582
    [No Abstract]   [Full Text] [Related]  

  • 30. [The super pill that prevents myocardial infarction].
    Jørgensen J
    Tidsskr Nor Laegeforen; 1992 Mar; 112(9):1205. PubMed ID: 1579949
    [No Abstract]   [Full Text] [Related]  

  • 31. Expert perspective: reducing cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoprotein cholesterol lowering.
    Jones PH
    Am J Cardiol; 2008 Dec; 102(12A):41L-47L. PubMed ID: 19084089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Higher dose of statin medication may be better for older adults.
    Mayo Clin Womens Healthsource; 2007 Dec; 11(12):3. PubMed ID: 17993998
    [No Abstract]   [Full Text] [Related]  

  • 33. [Lowering cholesterol in the elderly--yes, no, or maybe?].
    Gogol M
    MMW Fortschr Med; 2006 Mar; 148(12):40-3. PubMed ID: 16626005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Further studies are required: in spite of positive effects of statins many patients still develop myocardial infarction].
    Werkö L
    Lakartidningen; 1998 Dec; 95(49):5654-5. PubMed ID: 9863308
    [No Abstract]   [Full Text] [Related]  

  • 35. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people.
    Schramm TK; Gislason GH; Køber L; Rasmussen S; Rasmussen JN; Abildstrøm SZ; Hansen ML; Folke F; Buch P; Madsen M; Vaag A; Torp-Pedersen C
    Circulation; 2008 Apr; 117(15):1945-54. PubMed ID: 18378618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum paraoxonase-I activity is unaffected by short-term administration of simvastatin, bezafibrate, and their combination in type 2 diabetes mellitus.
    Dullaart RP; de Vries R; Voorbij HA; Sluiter WJ; van Tol A
    Eur J Clin Invest; 2009 Mar; 39(3):200-3. PubMed ID: 19260949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype: a prospective double-blinded clinical trial.
    Milman U; Blum S; Shapira C; Aronson D; Miller-Lotan R; Anbinder Y; Alshiek J; Bennett L; Kostenko M; Landau M; Keidar S; Levy Y; Khemlin A; Radan A; Levy AP
    Arterioscler Thromb Vasc Biol; 2008 Feb; 28(2):341-7. PubMed ID: 18032779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Low carbohydrate diets reduce the need of statin treatment].
    Ravnskov U
    Lakartidningen; 2006 Oct 4-10; 103(40):3017; author reply 3017-8. PubMed ID: 17115674
    [No Abstract]   [Full Text] [Related]  

  • 39. [Lowering of LDL cholesterol prevents cardiovascular diseases. "Normal values" are too high--treatment time is a crucial factor].
    Rudling M
    Lakartidningen; 2006 Oct 25-31; 103(43):3278-82. PubMed ID: 17117659
    [No Abstract]   [Full Text] [Related]  

  • 40. My wife and I take a multivitamin that contains iron. I've heard that too much iron can increase my risk of having a heart attack. Should I stop taking the iron?
    Mayo Clin Health Lett; 2000 Sep; 18(9):8. PubMed ID: 10967728
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.